کارخانجاتداروپخش
دارو | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,690 2.43
Close Price: 9,400
Income Statement
AGM
Interim
2026/06/17 Fiscal Year 2026/03/2012 Month | 2025/05/28 Fiscal Year 2025/03/2012 Month | 2024/06/02 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 86.362 Trillion | 37.199 Trillion | 36.065 Trillion | |
Total Revenues | 86.362 Trillion | 37.199 Trillion | 36.065 Trillion | |
Cost of Goods Sold | 41.692 Trillion | 24.007 Trillion | 25.619 Trillion | |
Gross Profit | 44.669 Trillion | 13.193 Trillion | 10.446 Trillion | |
General & Administrative Expenses | 2.138 Trillion | 1.269 Trillion | 1.04 Trillion | |
Net Operating Income & Expenses | -488.803 Billion | -636.304 Billion | 66.86 Billion | |
Operating Profit (Loss) | 42.043 Trillion | 11.288 Trillion | 9.474 Trillion | |
Profit Before Tax | 36.457 Trillion | 7.002 Trillion | 5.03 Trillion | |
Tax | 9.621 Trillion | 1.576 Trillion | 1.792 Trillion | |
Net Profit (Loss) After Tax | 26.836 Trillion | 5.426 Trillion | 3.238 Trillion | |
Retained Earnings at Beginning of Period | 6.975 Trillion | 4.15 Trillion | 9.059 Trillion | |
Approved Dividends — Prior Year AGM | -2.782 Trillion | -2.6 Trillion | -8.151 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -1.4 Trillion | -729 Million | 4.442 Billion | |
Transfer from Other Equity Items | 14.499 Billion | - | - | |
Allocable Profit | 29.643 Trillion | 6.975 Trillion | 4.15 Trillion | |
Legal Reserve | 1.39 Trillion | - | - | |
Approved Dividends — Current Year | 13.468 Trillion | 2.782 Trillion | 2.6 Trillion | |
Retained Earnings at End of Period | 14.785 Trillion | 4.193 Trillion | 1.55 Trillion |